Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • Categories
    • Medical Science
    • Health Awareness
  • Bookmarks
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > Govt Health > Reliance-Backed NK Holdings & Jupiter Hospital Battle for SevenHills Mumbai Hospital in ₹450 Cr Insolvency Bid

Reliance-Backed NK Holdings & Jupiter Hospital Battle for SevenHills Mumbai Hospital in ₹450 Cr Insolvency Bid

Published: December 29, 2025
SHARE

Reliance Industries-backed NK Holdings and listed chain Jupiter Hospital have emerged as frontrunners to acquire the iconic 1,500-bed SevenHills Hospital in Mumbai, currently under insolvency. Both have submitted resolution plans valued at around ₹450 crore, differing primarily in payment terms Jupiter offering full upfront payment versus NK’s staggered five-year schedule as creditors weigh faster recovery against the asset’s revival potential after years of legal disputes.

Glimpse:

SevenHills Healthcare’s Mumbai facility, built on civic land via a public-private partnership, has been in NCLT insolvency since 2018 amid disputes with the Municipal Corporation of Greater Mumbai (MCGM) over unpaid rent. With admitted claims exceeding ₹1,361 crore (as of March 2023), the separate sale of its Visakhapatnam unit (to MGM Healthcare for ₹171 crore in 2024) has paved the way for this bidding war. The outcome hinges on NCLT approval and creditor preferences for immediate versus deferred payouts.

A high-stakes acquisition battle is unfolding for SevenHills Healthcare’s flagship 1,500-bed hospital in Mumbai’s Andheri suburb, with Reliance Industries-backed NK Holdings and Pune-based Jupiter Hospital submitting competing resolution plans under the ongoing insolvency process. Both bidders have valued the asset at approximately ₹450 crore, but their proposals diverge sharply on payment structure, setting the stage for creditors to prioritize speed of recovery.

Jupiter Hospital has proposed paying the entire ₹450 crore upfront within 30 days of NCLT approval, appealing to lenders seeking swift liquidity after prolonged delays. In contrast, NK Holdings supported by Reliance’s deep pockets has offered the same amount spread over five years, potentially allowing for sustained investment in operational revival.

The Mumbai hospital, spread across 17 acres of land leased from the Municipal Corporation of Greater Mumbai (MCGM), was envisioned as a landmark PPP project but plunged into crisis due to disputes over unpaid rent and lease terms. Admitted to insolvency in March 2018, it faced multiple failed resolutions, including a ₹1,000-crore plan by Narayana Health’s founder Dr. Devi Shetty in 2019 (overturned by the Supreme Court). During the COVID-19 pandemic, it served as a dedicated facility but operations remained hampered.

To expedite resolution, NCLT permitted separate sales of the Mumbai and Visakhapatnam assets. The latter a 300-bed facility was acquired by MGM Healthcare for ₹171 crore in July 2024. For Mumbai, MCGM’s ₹140.8 crore unpaid rent claim remains contested, while financial creditors hold the bulk of ₹1,273 crore in admitted claims (total ₹1,361 crore as of March 2023).

This bidding round follows renewed interest post-pandemic, with earlier expressions from chains like Max Healthcare, KIMS, and Virinchi. The successful bidder will gain a prime, large-scale asset near Mumbai’s international airport, ideal for multi-specialty expansion in a high-demand market.

The process underscores India’s consolidating hospital sector, where corporate players like Reliance (expanding healthcare footprint) and Jupiter (aggressive inorganic growth) vie for distressed assets to scale quickly.

“Both bidders have offered around ₹450 crore, but with differing payment schedules creating a strategic decision point for creditors seeking resolution after years of delays.”

By

HB Team

Related News

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

India–UK Biotech Corridor Launched to Power Next Wave of Life Sciences Innovation

April 23, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Eli Lilly Strikes $7B Deal to Supercharge Next Gen Cancer Therapies

April 22, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

Siemens Healthineers Explores Karnataka Partnership to Build Future Ready HealthTech Hubs

April 18, 2026

Eli Lilly Eyes Kelonia Buyout to Accelerate Next Gen Cancer Therapies

April 20, 2026

Anlon Healthcare Acquires Remember India Health Links to Enter Formulations Market

April 17, 2026

Aurobindo’s Theranym Biologics to Invest Up to $175M in New Biologics Manufacturing Facility

April 17, 2026

GSK Completes $950M 35Pharma Acquisition to Strengthen Biologics and Cardiopulmonary Pipeline

April 16, 2026

Maharashtra FDA Proposes ₹500 Crore Plan to Modernise Drug Testing Labs and Strengthen Regulatory Framework

April 16, 2026

NIPER Mohali Signs Pact with Novartis to Boost Pharmaceutical Research and Innovation in India

April 16, 2026

Biocon Appoints Mandar Ghatnekar as Chief Technology Officer to Accelerate Digital and AI Transformation

April 10, 2026

Serum Institute and Trivitron Gear Up for Major Push into Global Diagnostics via MyLab JV

April 7, 2026

Serum Institute in Advanced Talks with Trivitron to Take MyLab Discovery Global via New Joint Venture

April 7, 2026

Alkem Laboratories Doubles Investment to ₹1,036 Crore for New Greenfield Formulations Facility in Ujjain

April 4, 2026

UPSIDA Signs MoU with JNPA to Transform Lalitpur Pharma Park into Global Export Hub

April 6, 2026
Microsoft’s Dragon Copilot Rolls Out at Mount Sinai to Support Clinicians
AvaSure Earns Epic Toolbox Designation for Inpatient Virtual Care Integration
Community Health Systems to Sell Four Arkansas Hospitals to Freeman Health System for $112 Million
AI in Healthcare! Transformative Promise Meets Real-World Hurdles
UAE Launches Amal! First AI Physician Assistant to Boost Patient Care
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Content Complaince

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?